aluates Reports

$ 0.0

Automative

Global Cellular and Gene Therapy CDMO Market Research Report 2024

Published Date: June 2024

Report Code: QYRE-Auto-13V14581

Global Cellular and Gene Therapy CDMO Market Research Report 2023

BUY CHAPTERS

Global Cellular and Gene Therapy CDMO Market Research Report 2024

Code: QYRE-Auto-13V14581

Report

June 2024

Pages:108

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Cellular and Gene Therapy CDMO Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Cellular and Gene Therapy CDMO Market

The global Cellular and Gene Therapy CDMO market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Cellular and Gene Therapy CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cellular and Gene Therapy CDMO.

Report Scope

The Cellular and Gene Therapy CDMO market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cellular and Gene Therapy CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cellular and Gene Therapy CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cellular and Gene Therapy CDMO Market Report

Report Metric	Details
Report Name	Cellular and Gene Therapy CDMO Market
CAGR	5%
Segment by Type	Cell Therapy Viral Vectors Plasmid
Segment by Application	Commercial Academic Research Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Catalent, Lonza, Charles River, The Discovery Labs, BIOCENTRIQ, FUJIFILM Diosynth Biotechnologies, Exothera, WuXi AppTec, Pharmaron, OBiO, Cell Therapies, AGC Biologics, Cytiva, Helixmith, ThermoGenesis, Anemocyte, Thermo Fisher Scientific, CBM, Bio Elpida, Genezen, CCRM, RoslinCT, GenScript ProBio, Oxford BioMedica, Porton Pharma Solutions
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cellular and Gene Therapy CDMO companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cellular and Gene Therapy CDMO Market report?

Ans: The main players in the Cellular and Gene Therapy CDMO Market are Catalent, Lonza, Charles River, The Discovery Labs, BIOCENTRIQ, FUJIFILM Diosynth Biotechnologies, Exothera, WuXi AppTec, Pharmaron, OBiO, Cell Therapies, AGC Biologics, Cytiva, Helixmith, ThermoGenesis, Anemocyte, Thermo Fisher Scientific, CBM, Bio Elpida, Genezen, CCRM, RoslinCT, GenScript ProBio, Oxford BioMedica, Porton Pharma Solutions

What are the Application segmentation covered in the Cellular and Gene Therapy CDMO Market report?

Ans: The Applications covered in the Cellular and Gene Therapy CDMO Market report are Commercial, Academic Research, Others

What are the Type segmentation covered in the Cellular and Gene Therapy CDMO Market report?

Ans: The Types covered in the Cellular and Gene Therapy CDMO Market report are Cell Therapy, Viral Vectors, Plasmid

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cellular and Gene Therapy CDMO Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Cell Therapy

1.2.3 Viral Vectors

1.2.4 Plasmid

1.3 Market by Application

1.3.1 Global Cellular and Gene Therapy CDMO Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Commercial

1.3.3 Academic Research

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cellular and Gene Therapy CDMO Market Perspective (2019-2030)

2.2 Cellular and Gene Therapy CDMO Growth Trends by Region

2.2.1 Global Cellular and Gene Therapy CDMO Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Cellular and Gene Therapy CDMO Historic Market Size by Region (2019-2024)

2.2.3 Cellular and Gene Therapy CDMO Forecasted Market Size by Region (2025-2030)

2.3 Cellular and Gene Therapy CDMO Market Dynamics

2.3.1 Cellular and Gene Therapy CDMO Industry Trends

2.3.2 Cellular and Gene Therapy CDMO Market Drivers

2.3.3 Cellular and Gene Therapy CDMO Market Challenges

2.3.4 Cellular and Gene Therapy CDMO Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cellular and Gene Therapy CDMO Players by Revenue

3.1.1 Global Top Cellular and Gene Therapy CDMO Players by Revenue (2019-2024)

3.1.2 Global Cellular and Gene Therapy CDMO Revenue Market Share by Players (2019-2024)

3.2 Global Cellular and Gene Therapy CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Cellular and Gene Therapy CDMO Revenue

3.4 Global Cellular and Gene Therapy CDMO Market Concentration Ratio

3.4.1 Global Cellular and Gene Therapy CDMO Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cellular and Gene Therapy CDMO Revenue in 2023

3.5 Cellular and Gene Therapy CDMO Key Players Head office and Area Served

3.6 Key Players Cellular and Gene Therapy CDMO Product Solution and Service

3.7 Date of Enter into Cellular and Gene Therapy CDMO Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Cellular and Gene Therapy CDMO Breakdown Data by Type

4.1 Global Cellular and Gene Therapy CDMO Historic Market Size by Type (2019-2024)

4.2 Global Cellular and Gene Therapy CDMO Forecasted Market Size by Type (2025-2030)

5 Cellular and Gene Therapy CDMO Breakdown Data by Application

5.1 Global Cellular and Gene Therapy CDMO Historic Market Size by Application (2019-2024)

5.2 Global Cellular and Gene Therapy CDMO Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Cellular and Gene Therapy CDMO Market Size (2019-2030)

6.2 North America Cellular and Gene Therapy CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Cellular and Gene Therapy CDMO Market Size by Country (2019-2024)

6.4 North America Cellular and Gene Therapy CDMO Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cellular and Gene Therapy CDMO Market Size (2019-2030)

7.2 Europe Cellular and Gene Therapy CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Cellular and Gene Therapy CDMO Market Size by Country (2019-2024)

7.4 Europe Cellular and Gene Therapy CDMO Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Cellular and Gene Therapy CDMO Market Size (2019-2030)

8.2 Asia-Pacific Cellular and Gene Therapy CDMO Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Cellular and Gene Therapy CDMO Market Size by Region (2019-2024)

8.4 Asia-Pacific Cellular and Gene Therapy CDMO Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Cellular and Gene Therapy CDMO Market Size (2019-2030)

9.2 Latin America Cellular and Gene Therapy CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Cellular and Gene Therapy CDMO Market Size by Country (2019-2024)

9.4 Latin America Cellular and Gene Therapy CDMO Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cellular and Gene Therapy CDMO Market Size (2019-2030)

10.2 Middle East & Africa Cellular and Gene Therapy CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Cellular and Gene Therapy CDMO Market Size by Country (2019-2024)

10.4 Middle East & Africa Cellular and Gene Therapy CDMO Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Catalent

11.1.1 Catalent Company Detail

11.1.2 Catalent Business Overview

11.1.3 Catalent Cellular and Gene Therapy CDMO Introduction

11.1.4 Catalent Revenue in Cellular and Gene Therapy CDMO Business (2019-2024)

11.1.5 Catalent Recent Development

11.2 Lonza

11.2.1 Lonza Company Detail

11.2.2 Lonza Business Overview

11.2.3 Lonza Cellular and Gene Therapy CDMO Introduction

11.2.4 Lonza Revenue in Cellular and Gene Therapy CDMO Business (2019-2024)

11.2.5 Lonza Recent Development

11.3 Charles River

11.3.1 Charles River Company Detail

11.3.2 Charles River Business Overview

11.3.3 Charles River Cellular and Gene Therapy CDMO Introduction

11.3.4 Charles River Revenue in Cellular and Gene Therapy CDMO Business (2019-2024)

11.3.5 Charles River Recent Development

11.4 The Discovery Labs

11.4.1 The Discovery Labs Company Detail

11.4.2 The Discovery Labs Business Overview

11.4.3 The Discovery Labs Cellular and Gene Therapy CDMO Introduction

11.4.4 The Discovery Labs Revenue in Cellular and Gene Therapy CDMO Business (2019-2024)

11.4.5 The Discovery Labs Recent Development

11.5 BIOCENTRIQ

11.5.1 BIOCENTRIQ Company Detail

11.5.2 BIOCENTRIQ Business Overview

11.5.3 BIOCENTRIQ Cellular and Gene Therapy CDMO Introduction

11.5.4 BIOCENTRIQ Revenue in Cellular and Gene Therapy CDMO Business (2019-2024)

11.5.5 BIOCENTRIQ Recent Development

11.6 FUJIFILM Diosynth Biotechnologies

11.6.1 FUJIFILM Diosynth Biotechnologies Company Detail

11.6.2 FUJIFILM Diosynth Biotechnologies Business Overview

11.6.3 FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Introduction

11.6.4 FUJIFILM Diosynth Biotechnologies Revenue in Cellular and Gene Therapy CDMO Business (2019-2024)

11.6.5 FUJIFILM Diosynth Biotechnologies Recent Development

11.7 Exothera

11.7.1 Exothera Company Detail

11.7.2 Exothera Business Overview

11.7.3 Exothera Cellular and Gene Therapy CDMO Introduction

11.7.4 Exothera Revenue in Cellular and Gene Therapy CDMO Business (2019-2024)

11.7.5 Exothera Recent Development

11.8 WuXi AppTec

11.8.1 WuXi AppTec Company Detail

11.8.2 WuXi AppTec Business Overview

11.8.3 WuXi AppTec Cellular and Gene Therapy CDMO Introduction

11.8.4 WuXi AppTec Revenue in Cellular and Gene Therapy CDMO Business (2019-2024)

11.8.5 WuXi AppTec Recent Development

11.9 Pharmaron

11.9.1 Pharmaron Company Detail

11.9.2 Pharmaron Business Overview

11.9.3 Pharmaron Cellular and Gene Therapy CDMO Introduction

11.9.4 Pharmaron Revenue in Cellular and Gene Therapy CDMO Business (2019-2024)

11.9.5 Pharmaron Recent Development

11.10 OBiO

11.10.1 OBiO Company Detail

11.10.2 OBiO Business Overview

11.10.3 OBiO Cellular and Gene Therapy CDMO Introduction

11.10.4 OBiO Revenue in Cellular and Gene Therapy CDMO Business (2019-2024)

11.10.5 OBiO Recent Development

11.11 Cell Therapies

11.11.1 Cell Therapies Company Detail

11.11.2 Cell Therapies Business Overview

11.11.3 Cell Therapies Cellular and Gene Therapy CDMO Introduction

11.11.4 Cell Therapies Revenue in Cellular and Gene Therapy CDMO Business (2019-2024)

11.11.5 Cell Therapies Recent Development

11.12 AGC Biologics

11.12.1 AGC Biologics Company Detail

11.12.2 AGC Biologics Business Overview

11.12.3 AGC Biologics Cellular and Gene Therapy CDMO Introduction

11.12.4 AGC Biologics Revenue in Cellular and Gene Therapy CDMO Business (2019-2024)

11.12.5 AGC Biologics Recent Development

11.13 Cytiva

11.13.1 Cytiva Company Detail

11.13.2 Cytiva Business Overview

11.13.3 Cytiva Cellular and Gene Therapy CDMO Introduction

11.13.4 Cytiva Revenue in Cellular and Gene Therapy CDMO Business (2019-2024)

11.13.5 Cytiva Recent Development

11.14 Helixmith

11.14.1 Helixmith Company Detail

11.14.2 Helixmith Business Overview

11.14.3 Helixmith Cellular and Gene Therapy CDMO Introduction

11.14.4 Helixmith Revenue in Cellular and Gene Therapy CDMO Business (2019-2024)

11.14.5 Helixmith Recent Development

11.15 ThermoGenesis

11.15.1 ThermoGenesis Company Detail

11.15.2 ThermoGenesis Business Overview

11.15.3 ThermoGenesis Cellular and Gene Therapy CDMO Introduction

11.15.4 ThermoGenesis Revenue in Cellular and Gene Therapy CDMO Business (2019-2024)

11.15.5 ThermoGenesis Recent Development

11.16 Anemocyte

11.16.1 Anemocyte Company Detail

11.16.2 Anemocyte Business Overview

11.16.3 Anemocyte Cellular and Gene Therapy CDMO Introduction

11.16.4 Anemocyte Revenue in Cellular and Gene Therapy CDMO Business (2019-2024)

11.16.5 Anemocyte Recent Development

11.17 Thermo Fisher Scientific

11.17.1 Thermo Fisher Scientific Company Detail

11.17.2 Thermo Fisher Scientific Business Overview

11.17.3 Thermo Fisher Scientific Cellular and Gene Therapy CDMO Introduction

11.17.4 Thermo Fisher Scientific Revenue in Cellular and Gene Therapy CDMO Business (2019-2024)

11.17.5 Thermo Fisher Scientific Recent Development

11.18 CBM

11.18.1 CBM Company Detail

11.18.2 CBM Business Overview

11.18.3 CBM Cellular and Gene Therapy CDMO Introduction

11.18.4 CBM Revenue in Cellular and Gene Therapy CDMO Business (2019-2024)

11.18.5 CBM Recent Development

11.19 Bio Elpida

11.19.1 Bio Elpida Company Detail

11.19.2 Bio Elpida Business Overview

11.19.3 Bio Elpida Cellular and Gene Therapy CDMO Introduction

11.19.4 Bio Elpida Revenue in Cellular and Gene Therapy CDMO Business (2019-2024)

11.19.5 Bio Elpida Recent Development

11.20 Genezen

11.20.1 Genezen Company Detail

11.20.2 Genezen Business Overview

11.20.3 Genezen Cellular and Gene Therapy CDMO Introduction

11.20.4 Genezen Revenue in Cellular and Gene Therapy CDMO Business (2019-2024)

11.20.5 Genezen Recent Development

11.21 CCRM

11.21.1 CCRM Company Detail

11.21.2 CCRM Business Overview

11.21.3 CCRM Cellular and Gene Therapy CDMO Introduction

11.21.4 CCRM Revenue in Cellular and Gene Therapy CDMO Business (2019-2024)

11.21.5 CCRM Recent Development

11.22 RoslinCT

11.22.1 RoslinCT Company Detail

11.22.2 RoslinCT Business Overview

11.22.3 RoslinCT Cellular and Gene Therapy CDMO Introduction

11.22.4 RoslinCT Revenue in Cellular and Gene Therapy CDMO Business (2019-2024)

11.22.5 RoslinCT Recent Development

11.23 GenScript ProBio

11.23.1 GenScript ProBio Company Detail

11.23.2 GenScript ProBio Business Overview

11.23.3 GenScript ProBio Cellular and Gene Therapy CDMO Introduction

11.23.4 GenScript ProBio Revenue in Cellular and Gene Therapy CDMO Business (2019-2024)

11.23.5 GenScript ProBio Recent Development

11.24 Oxford BioMedica

11.24.1 Oxford BioMedica Company Detail

11.24.2 Oxford BioMedica Business Overview

11.24.3 Oxford BioMedica Cellular and Gene Therapy CDMO Introduction

11.24.4 Oxford BioMedica Revenue in Cellular and Gene Therapy CDMO Business (2019-2024)

11.24.5 Oxford BioMedica Recent Development

11.25 Porton Pharma Solutions

11.25.1 Porton Pharma Solutions Company Detail

11.25.2 Porton Pharma Solutions Business Overview

11.25.3 Porton Pharma Solutions Cellular and Gene Therapy CDMO Introduction

11.25.4 Porton Pharma Solutions Revenue in Cellular and Gene Therapy CDMO Business (2019-2024)

11.25.5 Porton Pharma Solutions Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

Table 1. Global Cellular and Gene Therapy CDMO Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Cell Therapy

Table 3. Key Players of Viral Vectors

Table 4. Key Players of Plasmid

Table 5. Global Cellular and Gene Therapy CDMO Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Cellular and Gene Therapy CDMO Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Cellular and Gene Therapy CDMO Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Cellular and Gene Therapy CDMO Market Share by Region (2019-2024)

Table 9. Global Cellular and Gene Therapy CDMO Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Cellular and Gene Therapy CDMO Market Share by Region (2025-2030)

Table 11. Cellular and Gene Therapy CDMO Market Trends

Table 12. Cellular and Gene Therapy CDMO Market Drivers

Table 13. Cellular and Gene Therapy CDMO Market Challenges

Table 14. Cellular and Gene Therapy CDMO Market Restraints

Table 15. Global Cellular and Gene Therapy CDMO Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Cellular and Gene Therapy CDMO Market Share by Players (2019-2024)

Table 17. Global Top Cellular and Gene Therapy CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cellular and Gene Therapy CDMO as of 2023)

Table 18. Ranking of Global Top Cellular and Gene Therapy CDMO Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Cellular and Gene Therapy CDMO Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Cellular and Gene Therapy CDMO Product Solution and Service

Table 22. Date of Enter into Cellular and Gene Therapy CDMO Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Cellular and Gene Therapy CDMO Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Cellular and Gene Therapy CDMO Revenue Market Share by Type (2019-2024)

Table 26. Global Cellular and Gene Therapy CDMO Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Cellular and Gene Therapy CDMO Revenue Market Share by Type (2025-2030)

Table 28. Global Cellular and Gene Therapy CDMO Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Cellular and Gene Therapy CDMO Revenue Market Share by Application (2019-2024)

Table 30. Global Cellular and Gene Therapy CDMO Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Cellular and Gene Therapy CDMO Revenue Market Share by Application (2025-2030)

Table 32. North America Cellular and Gene Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Cellular and Gene Therapy CDMO Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Cellular and Gene Therapy CDMO Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Cellular and Gene Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Cellular and Gene Therapy CDMO Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Cellular and Gene Therapy CDMO Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Cellular and Gene Therapy CDMO Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Cellular and Gene Therapy CDMO Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Cellular and Gene Therapy CDMO Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Cellular and Gene Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Cellular and Gene Therapy CDMO Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Cellular and Gene Therapy CDMO Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Cellular and Gene Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Cellular and Gene Therapy CDMO Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Cellular and Gene Therapy CDMO Market Size by Country (2025-2030) & (US$ Million)

Table 47. Catalent Company Detail

Table 48. Catalent Business Overview

Table 49. Catalent Cellular and Gene Therapy CDMO Product

Table 50. Catalent Revenue in Cellular and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 51. Catalent Recent Development

Table 52. Lonza Company Detail

Table 53. Lonza Business Overview

Table 54. Lonza Cellular and Gene Therapy CDMO Product

Table 55. Lonza Revenue in Cellular and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 56. Lonza Recent Development

Table 57. Charles River Company Detail

Table 58. Charles River Business Overview

Table 59. Charles River Cellular and Gene Therapy CDMO Product

Table 60. Charles River Revenue in Cellular and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 61. Charles River Recent Development

Table 62. The Discovery Labs Company Detail

Table 63. The Discovery Labs Business Overview

Table 64. The Discovery Labs Cellular and Gene Therapy CDMO Product

Table 65. The Discovery Labs Revenue in Cellular and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 66. The Discovery Labs Recent Development

Table 67. BIOCENTRIQ Company Detail

Table 68. BIOCENTRIQ Business Overview

Table 69. BIOCENTRIQ Cellular and Gene Therapy CDMO Product

Table 70. BIOCENTRIQ Revenue in Cellular and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 71. BIOCENTRIQ Recent Development

Table 72. FUJIFILM Diosynth Biotechnologies Company Detail

Table 73. FUJIFILM Diosynth Biotechnologies Business Overview

Table 74. FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Product

Table 75. FUJIFILM Diosynth Biotechnologies Revenue in Cellular and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 76. FUJIFILM Diosynth Biotechnologies Recent Development

Table 77. Exothera Company Detail

Table 78. Exothera Business Overview

Table 79. Exothera Cellular and Gene Therapy CDMO Product

Table 80. Exothera Revenue in Cellular and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 81. Exothera Recent Development

Table 82. WuXi AppTec Company Detail

Table 83. WuXi AppTec Business Overview

Table 84. WuXi AppTec Cellular and Gene Therapy CDMO Product

Table 85. WuXi AppTec Revenue in Cellular and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 86. WuXi AppTec Recent Development

Table 87. Pharmaron Company Detail

Table 88. Pharmaron Business Overview

Table 89. Pharmaron Cellular and Gene Therapy CDMO Product

Table 90. Pharmaron Revenue in Cellular and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 91. Pharmaron Recent Development

Table 92. OBiO Company Detail

Table 93. OBiO Business Overview

Table 94. OBiO Cellular and Gene Therapy CDMO Product

Table 95. OBiO Revenue in Cellular and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 96. OBiO Recent Development

Table 97. Cell Therapies Company Detail

Table 98. Cell Therapies Business Overview

Table 99. Cell Therapies Cellular and Gene Therapy CDMO Product

Table 100. Cell Therapies Revenue in Cellular and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 101. Cell Therapies Recent Development

Table 102. AGC Biologics Company Detail

Table 103. AGC Biologics Business Overview

Table 104. AGC Biologics Cellular and Gene Therapy CDMO Product

Table 105. AGC Biologics Revenue in Cellular and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 106. AGC Biologics Recent Development

Table 107. Cytiva Company Detail

Table 108. Cytiva Business Overview

Table 109. Cytiva Cellular and Gene Therapy CDMO Product

Table 110. Cytiva Revenue in Cellular and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 111. Cytiva Recent Development

Table 112. Helixmith Company Detail

Table 113. Helixmith Business Overview

Table 114. Helixmith Cellular and Gene Therapy CDMO Product

Table 115. Helixmith Revenue in Cellular and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 116. Helixmith Recent Development

Table 117. ThermoGenesis Company Detail

Table 118. ThermoGenesis Business Overview

Table 119. ThermoGenesis Cellular and Gene Therapy CDMO Product

Table 120. ThermoGenesis Revenue in Cellular and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 121. ThermoGenesis Recent Development

Table 122. Anemocyte Company Detail

Table 123. Anemocyte Business Overview

Table 124. Anemocyte Cellular and Gene Therapy CDMO Product

Table 125. Anemocyte Revenue in Cellular and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 126. Anemocyte Recent Development

Table 127. Thermo Fisher Scientific Company Detail

Table 128. Thermo Fisher Scientific Business Overview

Table 129. Thermo Fisher Scientific Cellular and Gene Therapy CDMO Product

Table 130. Thermo Fisher Scientific Revenue in Cellular and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 131. Thermo Fisher Scientific Recent Development

Table 132. CBM Company Detail

Table 133. CBM Business Overview

Table 134. CBM Cellular and Gene Therapy CDMO Product

Table 135. CBM Revenue in Cellular and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 136. CBM Recent Development

Table 137. Bio Elpida Company Detail

Table 138. Bio Elpida Business Overview

Table 139. Bio Elpida Cellular and Gene Therapy CDMO Product

Table 140. Bio Elpida Revenue in Cellular and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 141. Bio Elpida Recent Development

Table 142. Genezen Company Detail

Table 143. Genezen Business Overview

Table 144. Genezen Cellular and Gene Therapy CDMO Product

Table 145. Genezen Revenue in Cellular and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 146. Genezen Recent Development

Table 147. CCRM Company Detail

Table 148. CCRM Business Overview

Table 149. CCRM Cellular and Gene Therapy CDMO Product

Table 150. CCRM Revenue in Cellular and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 151. CCRM Recent Development

Table 152. RoslinCT Company Detail

Table 153. RoslinCT Business Overview

Table 154. RoslinCT Cellular and Gene Therapy CDMO Product

Table 155. RoslinCT Revenue in Cellular and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 156. RoslinCT Recent Development

Table 157. GenScript ProBio Company Detail

Table 158. GenScript ProBio Business Overview

Table 159. GenScript ProBio Cellular and Gene Therapy CDMO Product

Table 160. GenScript ProBio Revenue in Cellular and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 161. GenScript ProBio Recent Development

Table 162. Oxford BioMedica Company Detail

Table 163. Oxford BioMedica Business Overview

Table 164. Oxford BioMedica Cellular and Gene Therapy CDMO Product

Table 165. Oxford BioMedica Revenue in Cellular and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 166. Oxford BioMedica Recent Development

Table 167. Porton Pharma Solutions Company Detail

Table 168. Porton Pharma Solutions Business Overview

Table 169. Porton Pharma Solutions Cellular and Gene Therapy CDMO Product

Table 170. Porton Pharma Solutions Revenue in Cellular and Gene Therapy CDMO Business (2019-2024) & (US$ Million)

Table 171. Porton Pharma Solutions Recent Development

Table 172. Research Programs/Design for This Report

Table 173. Key Data Information from Secondary Sources

Table 174. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Cellular and Gene Therapy CDMO Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Cellular and Gene Therapy CDMO Market Share by Type: 2023 VS 2030

Figure 3. Cell Therapy Features

Figure 4. Viral Vectors Features

Figure 5. Plasmid Features

Figure 6. Global Cellular and Gene Therapy CDMO Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Cellular and Gene Therapy CDMO Market Share by Application: 2023 VS 2030

Figure 8. Commercial Case Studies

Figure 9. Academic Research Case Studies

Figure 10. Others Case Studies

Figure 11. Cellular and Gene Therapy CDMO Report Years Considered

Figure 12. Global Cellular and Gene Therapy CDMO Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Cellular and Gene Therapy CDMO Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Cellular and Gene Therapy CDMO Market Share by Region: 2023 VS 2030

Figure 15. Global Cellular and Gene Therapy CDMO Market Share by Players in 2023

Figure 16. Global Top Cellular and Gene Therapy CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cellular and Gene Therapy CDMO as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Cellular and Gene Therapy CDMO Revenue in 2023

Figure 18. North America Cellular and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Cellular and Gene Therapy CDMO Market Share by Country (2019-2030)

Figure 20. United States Cellular and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Cellular and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Cellular and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Cellular and Gene Therapy CDMO Market Share by Country (2019-2030)

Figure 24. Germany Cellular and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Cellular and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Cellular and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Cellular and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Cellular and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Cellular and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Cellular and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Cellular and Gene Therapy CDMO Market Share by Region (2019-2030)

Figure 32. China Cellular and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Cellular and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Cellular and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Cellular and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Cellular and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Cellular and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Cellular and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Cellular and Gene Therapy CDMO Market Share by Country (2019-2030)

Figure 40. Mexico Cellular and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Cellular and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Cellular and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Cellular and Gene Therapy CDMO Market Share by Country (2019-2030)

Figure 44. Turkey Cellular and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Cellular and Gene Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Catalent Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2019-2024)

Figure 47. Lonza Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2019-2024)

Figure 48. Charles River Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2019-2024)

Figure 49. The Discovery Labs Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2019-2024)

Figure 50. BIOCENTRIQ Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2019-2024)

Figure 51. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2019-2024)

Figure 52. Exothera Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2019-2024)

Figure 53. WuXi AppTec Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2019-2024)

Figure 54. Pharmaron Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2019-2024)

Figure 55. OBiO Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2019-2024)

Figure 56. Cell Therapies Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2019-2024)

Figure 57. AGC Biologics Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2019-2024)

Figure 58. Cytiva Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2019-2024)

Figure 59. Helixmith Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2019-2024)

Figure 60. ThermoGenesis Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2019-2024)

Figure 61. Anemocyte Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2019-2024)

Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2019-2024)

Figure 63. CBM Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2019-2024)

Figure 64. Bio Elpida Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2019-2024)

Figure 65. Genezen Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2019-2024)

Figure 66. CCRM Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2019-2024)

Figure 67. RoslinCT Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2019-2024)

Figure 68. GenScript ProBio Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2019-2024)

Figure 69. Oxford BioMedica Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2019-2024)

Figure 70. Porton Pharma Solutions Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2019-2024)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-30I2390

Tue Oct 15 00:00:00 UTC 2024

Add to Cart

Healthcare Inventory Management - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-6L2758

Tue Oct 15 00:00:00 UTC 2024

Add to Cart

Blood Tubing Systems - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-32Y957

Tue Oct 15 00:00:00 UTC 2024

Add to Cart

ePharmacy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-4C2008

Fri Oct 11 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Cellular and Gene Therapy CDMO Market Research Report 2024

Published Date: June 2024

Report Code: QYRE-Auto-13V14581

Global Cellular and Gene Therapy CDMO Market Research Report 2024

FEATURED COMPANIES

Cellular and Gene Therapy CDMO Market Size

Cellular and Gene Therapy CDMO Market

Report Scope

Scope of Cellular and Gene Therapy CDMO Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Cellular and Gene Therapy CDMO Market report?

What are the Application segmentation covered in the Cellular and Gene Therapy CDMO Market report?

What are the Type segmentation covered in the Cellular and Gene Therapy CDMO Market report?

FEATURED COMPANIES

RELATED REPORTS